Trial intelligence / Profile preview

Folic acid supplementation and plasma homocysteine in methotrexate-treated psoriasis

2004-002306-29Phase 4Unknown

Sponsor
Liverpool University Hospitals NHS Foundation Trust
Start
Feb 2005
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 4 trial of folic acid in psoriasis, sponsored by Liverpool University Hospitals NHS Foundation Trust. Primary endpoint: Completion of 12 weeks. Status: unknown.

02

Drugs

folic acid
03

Conditions

psoriasis

Beyond the preview

Go deeper on 2004-002306-29.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2004-002306-29.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call